We’ve developed a unique technology to produce commercial grade, sustained-release microparticulate protein therapeutics suitable for parenteral, oral, and mucosal delivery.
We aggressively file new patent applications to protect our technology, inventions, and improvements.
Therapyx has teamed up with world-class oncologists at the University of Rochester to meet the challenges of pancreatic cancer.
Therapyx has teamed up with Intravacc to develop the world’s first therapeutic and prophylactic vaccines against gonorrhea.
We're changing the future of pharmaceuticals. Learn more about the company behind the innovation.
